SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Revenue (TTM)
$15.62M
Q1 May 2023
Net Income (TTM)
−$71.42M
+52.5% YoY
Q1 May 2023
EPS Diluted (TTM)
−$0.40
+59.8% YoY
Q1 May 2023
Gross Margin
-157.7%
Q1 May 2023
Operating Margin
-422.2%
Q1 May 2023
Net Margin
-457.4%
Q1 May 2023
Free Cash Flow (TTM)
−$121.19M
Q1 May 2023
Cash
$52.37M
Q1 May 2023
Total Debt
$28.84M
Q1 May 2023
Shares Outstanding
205.26M sh
Q1 May 2023
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.